Alfacalcidol (Alfacalcidol)


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 27.9%
Surgery 20.9%
Hyperphosphataemia 9.3%
Prophylaxis Urinary Tract Infection 9.3%
Multiple Myeloma 7.0%
Hyperparathyroidism 4.7%
Osteoporosis 4.7%
Prophylaxis 4.7%
Skin Ulcer 4.7%
Asthma 2.3%
Epilepsy 2.3%
Urinary Tract Infection 2.3%
Visual Acuity Reduced 22.2%
Blister 11.1%
Optic Disc Disorder 11.1%
Papule 11.1%
Renal Impairment 11.1%
Treatment Noncompliance 11.1%
Vitamin D Decreased 11.1%
Weight Increased 11.1%
Concomitant
Renal Transplant 11.3%
Pulmonary Hypertension 9.3%
Product Used For Unknown Indication 8.7%
Antiviral Prophylaxis 8.0%
Diffuse Large B-cell Lymphoma 6.7%
Pulmonary Arterial Hypertension 6.7%
Rheumatoid Arthritis 6.7%
Acute Myeloid Leukaemia 6.0%
Prophylaxis Against Transplant Rejection 5.3%
Osteoporosis 4.7%
Hiatus Hernia 3.3%
Lymphoma 3.3%
Fabry's Disease 2.7%
Gout 2.7%
Hyperphosphataemia 2.7%
Immunosuppression 2.7%
Nephrotic Syndrome 2.7%
Pneumonia 2.7%
Arthritis Bacterial 2.0%
Asthma 2.0%
White Blood Cell Count Decreased 11.9%
Tremor 9.0%
Vomiting 9.0%
Pneumonia 7.5%
Liver Function Test Abnormal 6.0%
Pyrexia 6.0%
Hepatic Function Abnormal 4.5%
Lower Respiratory Tract Infection 4.5%
Ovarian Cancer 4.5%
Rhabdomyolysis 4.5%
Sudden Death 4.5%
Tumour Lysis Syndrome 4.5%
Asthma 3.0%
Dyspnoea 3.0%
Fall 3.0%
Hypomagnesaemia 3.0%
Malaise 3.0%
Muscle Spasms 3.0%
Pain In Extremity 3.0%
Pancreatitis Acute 3.0%

Drug Data